Aquestive Therapeutics (AQST) Interest & Investment Income (2018 - 2026)
Aquestive Therapeutics (AQST) recorded quarterly Interest & Investment Income of $83000.0 in Q1 2026, down 93.37% quarter-over-quarter from $1.3 million in Q4 2025, and down 88.36% on a YoY basis from $713000.0 in Q1 2025.
Aquestive Therapeutics (AQST) Interest & Investment Income (2018 - 2026) Analysis & Trends
Aquestive Therapeutics' Interest & Investment Income history runs 9 years deep, the most recent figure standing at $83000.0 for Q1 2026.
- In Q1 2026, Interest & Investment Income fell 88.36% year-over-year to $83000.0; the TTM figure through Mar 2026 stood at $3.7 million (down 2.2% YoY), while the FY2025 annual figure was $4.4 million, up 27.06% from the prior year.
- Interest & Investment Income was $83000.0 for Q1 2026 at Aquestive Therapeutics, down from $1.3 million in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $14.5 million in Q1 2023 to a low of -$3000.0 in Q1 2022.
- Historically, Interest & Investment Income has averaged $1.4 million across 5 years, with a median of $329000.0 in 2024.
- The sharpest annual moves came in 2023 and 2024: Interest & Investment Income surged 483866.67% in 2023, then sank 97.73% in 2024.
- A 5-year view of Interest & Investment Income shows it stood at $65000.0 in 2022, then surged by 153.85% to $165000.0 in 2023, then surged by 344.85% to $734000.0 in 2024, then soared by 70.57% to $1.3 million in 2025, then plunged by 93.37% to $83000.0 in 2026.
- The last three Interest & Investment Income figures came in at $83000.0 (Q1 2026), $1.3 million (Q4 2025), and $306000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | 41.80 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | 3.45 Mn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 28.10 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | 8.54 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | 4.97 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | - |
| 10 | Aquestive Therapeutics | 487.99 Mn | 377.25 Mn | 10.98 Mn | 83,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 83,000.00 |
| Dec 31, 2025 | 1.25 Mn |
| Sep 30, 2025 | 306,000.00 |
| Jun 30, 2025 | 2.10 Mn |
| Mar 31, 2025 | 713,000.00 |
| Dec 31, 2024 | 734,000.00 |
| Sep 30, 2024 | 979,000.00 |
| Jun 30, 2024 | 1.40 Mn |
| Mar 31, 2024 | 329,000.00 |
| Dec 31, 2023 | 165,000.00 |
| Sep 30, 2023 | 1.51 Mn |
| Jun 30, 2023 | 129,000.00 |
| Mar 31, 2023 | 14.51 Mn |
| Dec 31, 2022 | 65,000.00 |
| Sep 30, 2022 | 5,000.00 |
| Jun 30, 2022 | 32,000.00 |
| Mar 31, 2022 | -3,000.00 |
| Dec 31, 2021 | 135,000.00 |
| Sep 30, 2021 | -33,000.00 |
| Jun 30, 2021 | 373,000.00 |